» Articles » PMID: 19081144

Overexpression of CNTF in Mesenchymal Stem Cells Reduces Demyelination and Induces Clinical Recovery in Experimental Autoimmune Encephalomyelitis Mice

Overview
Journal J Neuroimmunol
Specialty Neurology
Date 2008 Dec 17
PMID 19081144
Citations 40
Authors
Affiliations
Soon will be listed here.
Abstract

Human Mesenchymal Stem Cells (MSCs) were previously reported to ameliorate neuronal functional deficits in the MOG35-55-induced experimental autoimmune encephalomyelitis (EAE) mice by inducing T cell anergy. Human Ciliary neurotrophic factor (CNTF) recently was found to promote myelogenesis and reduce inflammation in CNTF-deficient EAE mice. We ectopically overexpressed CNTF in human MSCs to investigate its potential role in promoting remyelination and improving functional recovery in EAE mice. MSCs transfected by Ad-CNTF-IRES-EGFP (MSC-CNTF) were injected intravenously into EAE mice 10 days after the immunization. Neurological functional tests were scored daily by grading clinical signs (score 0-6). Immunofluorescence microscopy was used to detect MSC-CNTF in spinal cord. Expression of NG2, CNTF, and cleaved caspase-3 was measured by immunohistochemistry. CNTF expression was also analyzed by Western blot. Myelin was detected by Solochrome Cyanin staining. Our results found that CNTF concentration in MSC-CNTF cells was 20-fold higher than that in either MSC or Ad-EGFP-transfected MSCs (MSC-EGFP) in vitro. Mice receiving MSC-CNTF cells showed remarkable neuronal functional recovery: the cumulative clinical scores were significantly decreased, and the disease onset was statistically delayed. Mice receiving MSC-CNTF cells showed reduced TNF-alpha, IFN-gamma and increased the level of cytokine IL-10 in peripheral blood and a large number of MSC-CNTF cells were detected in the spleen, but were not detected in other organs such as lung, liver and kidney. In the lesions of these mice, 1) the number of cleaved caspase3-positive cells was significantly reduced; 2) MSC-CNTF- and NG2-positive cells were significantly increased; and 3) the expression of CNTF was dramatically increased. In addition, demyelination was significantly reduced in MSC-CNTF mice. These data indicated that MSC-CNTF may improve functional recovery in EAE mice, possibly by exerting their immunoregulatory activity, inhibiting inflammation, homing MSC-CNTF cells to the lesions, elevating CNTF expression, reducing demyelination, and stimulating oligodendrogenesis.

Citing Articles

Effects of Conditioned Media From Human Umbilical Cord-Derived Mesenchymal Stem Cells on Tenocytes From Degenerative Rotator Cuff Tears in an Interleukin 1β-Induced Tendinopathic Condition.

Lee M, Park K, Lee S, Jang K, Won S, Jo C Orthop J Sports Med. 2024; 12(11):23259671241286412.

PMID: 39534392 PMC: 11555721. DOI: 10.1177/23259671241286412.


The evolution of mesenchymal stem cell-derived neural progenitor therapy for Multiple Sclerosis: from concept to clinic.

Ghareghani M, Arneaud A, Rivest S Front Cell Neurosci. 2024; 18:1428652.

PMID: 39280795 PMC: 11393827. DOI: 10.3389/fncel.2024.1428652.


Modifying the Secretome of Mesenchymal Stem Cells Prolongs the Regenerative Treatment Window for Encephalopathy of Prematurity.

Vaes J, Onstwedder S, Trayford C, Gubbins E, Maas M, van Rijt S Int J Mol Sci. 2024; 25(12).

PMID: 38928201 PMC: 11203777. DOI: 10.3390/ijms25126494.


The Therapeutic Mechanisms of Mesenchymal Stem Cells in MS-A Review Focusing on Neuroprotective Properties.

Gavasso S, Krakenes T, Olsen H, Evjenth E, Ytterdal M, Haugsoen J Int J Mol Sci. 2024; 25(3).

PMID: 38338644 PMC: 10855165. DOI: 10.3390/ijms25031365.


Mesenchymal stem cell therapy for neurological disorders: The light or the dark side of the force?.

Isakovic J, Serer K, Barisic B, Mitrecic D Front Bioeng Biotechnol. 2023; 11:1139359.

PMID: 36926687 PMC: 10011535. DOI: 10.3389/fbioe.2023.1139359.